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Abstract
Background: The rise of personalized medicine has reminded us that each patient must be treated as an
individual. One factor in making treatment decisions is the physiological state of each patient, but definitions of
relevant states and methods to visualize state-related physiologic changes are scarce. We constructed correlation
networks from physiologic data to demonstrate changes associated with pressor use in the intensive care unit.
Methods: We collected 29 physiological variables at one-minute intervals from nineteen trauma patients in the
intensive care unit of an academic hospital and grouped each minute of data as receiving or not receiving
pressors. For each group we constructed Spearman correlation networks of pairs of physiologic variables. To
visualize drug-associated changes we split the networks into three components: an unchanging network, a
network of connections with changing correlation sign, and a network of connections only present in one group.
Results: Out of a possible 406 connections between the 29 physiological measures, 64, 39, and 48 were present in
each of the three component networks. The static network confirms expected physiological relationships while the
network of associations with changed correlation sign suggests putative changes due to the drugs. The network of
associations present only with pressors suggests new relationships that could be worthy of study.
Conclusions: We demonstrated that visualizing physiological relationships using correlation networks provides
insight into underlying physiologic states while also showing that many of these relationships change when the
state is defined by the presence of drugs. This method applied to targeted experiments could change the way
critical care patients are monitored and treated.
Background
A major goal of medical physiology has long been to fully
specify a model for how molecules and systems in the
body interact and react to changes in environment. Thus
far the most widely known and complete model of this
sort was produced by Guyton [1], systematically and math-
ematically detailing 354 independent elements that
together regulate cardiac output. A major and necessary
assumption inherent to this work and those that followed
is the capability of a single set of equations - a “physiology”
- to describe the ways in which systems and molecules
interact. While the concept of a single unified set of rela-
tionships to define physiology has certainly served both
science and medicine extremely well at the population
level, we now know (and, some would argue, have always
known) this view to be incorrect on the level of individuals
[2]. Regardless, the literature is full of population-based
studies that associate single physiological measures with
outcome. For example, many links have been made
between the variability of such measures - mostly heart
rate variability - to various adverse outcomes in a popula-
tion of trauma patients [3-7]. While valuable in advancing
medical knowledge the limits of population-based medi-
cine are becoming clearer. The rise of personalized medi-
cine via genomics, personalized dosing algorithms [8], and
genome wide association studies showing individual risk
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of disease are two obvious examples of such limitations of
population-based medicine [9,10].
Applying the concept of patient specificity to physiol-
ogy using multivariate data analysis and visualization
tools has recently found some traction. Nelson et al.
[11], using cerebral microdialysis, showed that patients
exhibited individualistic physiological patterns that were
also reflective of shock, but they could not find common
patterns between patients. Rixen et al [12] devised a
physiological state classifier based on seventeen variables
collected once daily, enabling prediction of patients’
deaths. Peleg et al [13] devised a biological simulator
based on multivariate physiological measurements.
Additionally, several patient-specific monitoring and
learning algorithms have been developed to improve
detection of severe and acute pathologies [14] and as
triage assistance and clinical decision support systems
[15,16]. Our own previous work has shown the depen-
dence of clinical assessment on data collection fre-
quency [17] and the benefits of combining multivariate
physiological data with continuous monitoring for
managing secondary brain injury and gaining clinical
insight not possible without such methods [18]. We
have also shown that physiological state as defined by
agglomerative hierarchical clustering leads to identifica-
tion of complex metabolic patterns naturally sorted for
outcome measures including death and multiple organ
failure [19].
One way to visualize and examine the interrelationships
of physiological measurements and how they change is by
using networks; this approach has become the basis for
large efforts to understand the relationships between
genetics and disease [20]. Networks constructed using cor-
related pairs of variables have found uses in many areas,
including integrative biology [21], metabolic networks
[22], gene expression networks [23], and even the struc-
ture of the Internet [24]. Furthermore, we have shown pre-
viously that physiological correlation networks changed
based on whether patients contracted an infection during
their stays in the intensive care unit (ICU) [25]. Because
physiology depends on disease state, we hypothesized that
the effects of another common modifier of physiology,
drugs, would be apparent when visualizing physiological
correlation networks and comparing the cases of the drugs
being given or not. Even if drugs are used that primarily
affect a single molecule, many drugs potentially have a
large set of off-target or side effects making broader
changes in physiology that we believe could be visualized
using clinical physiological networks.
To demonstrate this we examined the effects of admin-
istering pressors to patients in the ICU by collecting
high-frequency clinical physiological measurements and
using them to create correlation networks during times
when pressors were given during the normal course of
treatment and separately for times when they were not.
We then show that the structure of these networks chan-
ged when pressors were administered, with changes fall-
ing into two categories: the sign of the correlation
changed and correlations that appeared or disappeared
when pressors were given. We also provide an example
demonstrating that both patient individuality and drug
differences can visibly affect physiological relationships.
These methods could open the door to improved treat-
ment strategies for critical care patients, and may even
lead to clinically-relevant models of personalized physiol-




This study was approved by and conducted under
supervision of the Committee on Human Research at
the University of California San Francisco. We collected
physiological data from nineteen severely injured poly-
trauma patients from the intensive care unit at San
Francisco General Hospital between May 2004 and June
2005, as previously described [19,25]. Briefly, patients
were included based on admission to the ICU and a
requirement for ongoing resuscitation.
Patients were placed on respiratory support and stan-
dard ICU monitoring protocols using the bedside monitor.
Nine types of physiological data (Table 1) were collected
from these monitors at one-minute intervals and stored in
a database using a multimodal bioinformatics system
(Aristein Bioinformatics, Palo Alto, CA) that integrates
continuous data from the ventilator with other continuous
and intermittent measurements for a total of twenty-nine
physiological data streams. Clinical blood gas sampling
was supplemented with a point-of-care analyzer (Opti
CCA, Roche, Mannheim, Germany) and plasma lactate
levels were measured (Accutrend®, Roche). Patients’ non-
injured deltoid muscles were fitted with a muscle oxygen
catheter (Integra Neurosciences, Plainsboro, NY) as in [26]
to measure partial pressure of oxygen in muscle. Catheters
and monitoring took place for seven days or until the
patient was extubated. Patients were followed until dis-
charge or death and all complications were documented in
the database.
Additional data preparation has been described else-
where [25]. Briefly, data were collected, de-identified, inte-
grated into a single database, and hand-curated. Muscle
microdialysis data were interpolated, while all other mea-
sures were retained unaltered. All collected variables and
their abbreviations are summarized in Table 1.
Univariate data analysis
We grouped our minute-by-minute data from all
patients according to whether pressors were being given
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and used Wilcoxon-Mann-Whitney (Mann-Whitney U)
tests to determine whether the univariate physiological
measures came from the same underlying population in
those two cases. Bonferroni correction was used to cor-
rect for multiple comparisons with significance set at
p < 0.05.
Correlation network construction
We grouped all of our minute-by-minute data, regardless
of patient, according to whether pressors were being admi-
nistered during that minute, and calculated the Spearman
correlation coefficient for each possible pairing of physio-
logical measurements. We chose rank instead of linear
correlation to directly show the monotonic relationships
between variables without the need for them to be linear.
To maximize data utility, we calculated the correlation for
each pair of measurements using all those time points
containing data for both variables of that pair. While this
can yield a correlation matrix that is not positive definite,
we are concerned with the coefficients themselves rather
than manipulating the resulting matrix. We calculated the
p-value for each correlation using Student’s t-test on the
standard z-transform and used Bonferroni correction for
multiple comparisons. We considered a connection (edge)
between two physiological measures (nodes) to exist if the
correlation between them was statistically significant.
To assist in comparing the physiological correlation
network when pressors were given (“pressors on”) to the
one generated when they were not (“pressors off”), we
visualized the union of these two networks into three
interesting and distinct cases. The first, “static”, network
contains those connections present in both the “pressors
on” and “pressors off” networks, and with the same sign
of directionality in both cases. The second, “either-or”,
network consists of connections present in either of the
two networks, but not in both. The third, “sign-change”,
network consists of connections present both with and
without pressors being given, but with a different sign
of directionality in the two cases (i.e. positive correlation
in one network and negative correlation in the other).
Rather than simply display these networks as tables of
correlation values we visualize them as a network to
lend clarity. Each physiological variable becomes a node
and each significant correlation becomes a line connect-
ing the two relevant nodes. This way the differences in
correlation direction and strength can easily be seen
across the different conditions.
Individual patient comparison
We tested the null hypothesis that the slopes of two lin-
ear regressions are equal using the test [27]:
t =
β1 − β2√
σ 2Y1 (1− r21)
σ 2X1(N1 − 2)
+
σ 2Y2 (1− r22)
σ 2X2(N2 − 2)
,
(1)
where bi is the slope of the linear regression of the
sample Yi on Xi, ri
2 is the Pearson correlation coefficient
associated with that same regression, and sXi indicates
the sample standard deviation of Xi. The resulting statis-
tic follows a t distribution with N1 + N2 - 4 degrees of
freedom, where N1 and N2 are the numbers of samples
in the first and second groups, respectively. We com-
pared the regression slopes across the cases of receiving
and not receiving pressors within two individual
patients. We also compared the regression slopes of two
individuals at times when they were being given pressors
to times they were not.
Results
Patient demographics
We collected 29 different measures of clinical physiolo-
gical data from 19 individuals at one minute intervals,
each of which was admitted to the ICU as severely
injured trauma patients. As summarized in Table 2, our
patients had a mean injury severity score of 28 ± 10,
were in the ICU for an average of 24 days during a
Table 1 Types of data collected and their abbreviations.
Symbol Definition
PaO2/PCO2 Arterial O2/CO2 partial pressure
MAP Mean arterial blood pressure
HR Heart rate
MTemp Muscle oxygen temperature
PmO2 Muscle oxygen tension
SpO2 Oxygen saturation percentage





mLact Muscle lactate concentration
mGluc Muscle glucose concentration
mGlut Muscle glutamate concentration
mPyr Muscle pyruvate concentration
mLP Muscle lactate/pyruvate ratio
Lact.L Serum lactate
Gluc.F Bedside finger-stick glucose reading
Comp Mechanical lung compliance
PEEP Positive end expiratory pressure
MinVol Volume of air per minute
Ctemp Core temperature
CVP Central venous pressure
Hb/HCT Hemoglobin/hematocrit
Cl- Serum chloride
BUN Blood urea nitrogen
Cr Serum creatinine
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mean 40 day hospital stay. Standard monitoring was
initiated upon admission to the ICU while the full
experimental protocol was initiated shortly thereafter.
Data were then collected for a mean of 67 ± 48 hours.
Each patient had a minimum of 24 hours worth of data
collected, while 10 of 19 patients had at least 72 hours
worth of data. The mortality rate was 16%. None of the
above was associated with any treatment or outcome
measure.
Five of the patients received intravenous doses of pressor
drugs during their stay (Figure 1). Patient 2 received solely
dobutamine for the last 2/3 of the monitoring period
while Patient 12 received phenylephrine for a short period
in the middle of his stay. The other three patients received
combinations of pressor drugs at various times during
their stays; Patient 5 received simultaneous doses of three
drugs for the first part of his stay. In sum, 14,428 samples
(15.7%) were taken while pressors were administered out
of a total of 92,000 samples across all patients.
Effect of pressors on individual measures
Out of 29 types of physiological measures, 22 were sta-
tistically significantly different when pressors were given.
Figure 2 shows the univariate effects of administering
pressor drugs on four of these physiological measures
with three different types of significance. Finger-stick
glucose readings do not show a statistically significant
difference with or without pressors. Differences in core
temperature measurements (Figure 2b) are highly signif-
icantly associated with pressor use (p = 2 × 10-39), but
because the actual temperature shift is very small it is
likely not clinically meaningful except for the hypother-
mic data points. Two other measures showed a more
significant shift, both statistically and clinically. Muscle
oxygen tension(Figure 2c) shows a left shift, denoting a
decrease in overall muscle oxygenation in patients at the
time they are receiving pressors. The lactate:pyruvate
ratio for muscle undergoes a rightward shift (Figure 2d)
while pressors are being administered. Cumulative dis-
tribution functions for the other variables are shown in
Additional file 1. This method of univariate analysis can-
not be used to ascertain cause and effect, as clinical
signs of decreased muscle oxygenation likely leads clini-
cians to start pressors.
The core physiological network response to pressors
We next looked at the 406 possible pairings of the 29
physiological variables. We comprehensively computed
Spearman correlation coefficients for each pair of vari-
ables, using all data points when both variables were
simultaneously measured. We computed pair-wise corre-
lations separately using those data points associated with
both the absence and presence of pressors. To generate a
more complete picture of physiological changes concur-
rent with administering pressors, we used a correlation
network-based analysis to study the interrelationships
between our 29 clinical measurements. We visualized the
differences in these correlational networks in three ways
to highlight the similarities and differences in the physio-
logical relationships when pressors were given. The
“static” network is composed of those relationships that
exist and have the same sign of directionality in both
conditions and contains 64 out of a possible 406 edges
(Additional file 2). These relationships should therefore
include known physiology and serve as useful controls.
For example, hemoglobin and hematocrit are strongly
positively correlated both with and without pressors (r =
0.98, p < 10-20 in both cases). The three independent glu-
cose measurements are also all positively correlated (five
of six r > 0.62 with p < 10-8, exception: muscle and lab
glucose correlation was not significant with pressors on
due to lack of sufficient concurrent samples), as is base
excess with pH (r = 0.66 and 0.89, both p < 10-16).
Muscle oxygen tension is negatively correlated with mus-
cle lactate concentration (r = -0.28 and -0.65, p < 10-20)
and the lactate:pyruvate ratio (mLP) (r = -0.17 and -0.25,
p < 10-20) both with and without pressors, as would be









Gun shot wound 9 47
Pedestrians vs. auto 3 15
Fall/Jump 2 11
Other penetrating 2 11
MV/MC crash 2 11




Mean ± s.d. Range
Age (years) 38 ± 18 18 - 72
ICU length of stay (days) 24 ± 21 1 - 78
Hospital length of stay (days) 40 ± 42 1 - 172
ISS 28 ± 10 16 - 50
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expected since a reduction in oxygen available to muscle
should lead to an increase the relative amount of anaero-
bic respiration and the resulting lactate. Ventilation para-
meters are also correlated as expected; arterial oxygen,
oxygen saturation, and arterial oxygen:inspired oxygen
(PF) ratio are all positively correlated, while PF ratio is
anti-correlated with inspired oxygen fraction (all |r| >
0.46, all p < 10-7 with one p = 10-4). These findings reas-
sured us that our methodology was specific enough to re-
establish known, and intuitive physiological relations not
associated with pressors.
The second stage of analysis, the “either-or” network,
(Additional file 3) contains the 48 edges that exist either
while pressors were given or not, but not in both cases.
Twenty-nine edges are present only when pressors are
not. For example, blood urea nitrogen (BUN) and creati-
nine concentrations are strongly correlated without
pressors (r = 0.60, p << 10-60) but with pressors have
only a statistically insignificant negative correlation (r =
-0.06, p = 1). Nineteen edges are present only when
pressors are being given. As we have fewer measurements
with pressors than without, these correlations may be
more likely be indicative of physiological changes rather
than being anomalous due to large numbers of data
points. Interpreting these emerging relationships can be
difficult, as some may be reflective of the reason for
Figure 1 Timing and drug specification for the five patients who received pressors. The x-axis shows the entire time (in minutes) for
which we obtained comprehensive physiological data with time zero being the start of microdialysis catheter placement.
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giving pressors while others could be a consequence of
pressors. For example, the coupling between arterial and
muscle oxygen is associated with pressors (r = 0.55, p =
10-4). Since under normal conditions arterial oxygen
remains nearly saturated, one could hypothesize (and
eventually test) that oxygen transport is impaired at
times when pressors are given. While receiving pressors
pH becomes strongly negatively correlated with muscle
lactate (r = -0.76, p = 8 × 10-8) and with muscle pyruvate
(r = -0.86, p = 2 × 10-11), possibly indicating an increased
susceptibility to acidosis. Perhaps the most interesting of
our three analysis cases is what we term the “sign
change” network, consisting of those edges that are oppo-
sitely correlated depending on whether pressors are being
administered. Thirty-nine edges fall into this case (Addi-
tional file 4). While pressors were being given, the rela-
tionships between mean arterial pressure (MAP) and 8
other measures significantly change direction, in stark
contrast to the edges connecting MAP to three other
measures in both the static and either-or networks. The
relationships between oxygen saturation (SpO2) and
nearly all of the muscle microdialysis measures changed
from positive to negative correlations while pressors were
being given.
Figure 2 Empirical cumulative distribution functions. Empirical cumulative distribution functions for four physiological variables grouped
according to whether pressors were being administered (red) or not (blue). (a) Finger stick glucose readings do not differ significantly. (b) Core
body temperature undergoes a statistically significant difference but is unlikely to be clinically significant. (c) Muscle oxygen tension and (d)
muscle lactate:pyruvate ratio both show statistically significant changes upon administration of pressors and the changes appear to be clinically
different as well.
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Individual patients
Having shown that drugs alter correlation networks con-
structed from clinical physiological measurements, we
sought to determine how these changes affect individual
patients. To accomplish this we sought a way to narrow
our attention to a subset of the 151 edges from the
three networks discussed above and consequently chose
to restrict our attention to those edges that were most
highly correlated in our entire patient population and
defined a threshold for r accordingly. A cutoff of |r| >
0.4 provided a reasonable network size at a point where
the number of connected edges remained stable with
small variations in the cutoff (Figure 3). This reduced
the number of edges across all three networks to 58,
with a notably empty “sign change” network (Figure 4).
We then singled out patients 2 and 5 to help develop
a more nuanced understanding of how the global
network changes manifest in these individuals. For each
of the 58 relationships identified above (Figure 4) we
calculated the linear regression coefficients separately
when the patient was given and not given pressors and
tested for significant differences in three comparisons:
with and without pressors for each of patients 2 and 5,
and without pressors between patients 2 and 5. This
approach allows us to look not only at the strength of
association between two variables, but also shows the
more subtle ways in which these relationships vary. One
interesting example is the relationship between base
excess (BE) and blood pH (Figure 5), taken from the sta-
tic network. When pressors were not being given, i.e. in
the baseline state for each of patients 2 and 5, the slope
of the BE/pH relationship was significantly different.
When Patient 5 received pressors the slope of the rela-
tionship changed from his baseline, in contrast to
Figure 3 Number of edges in the correlation networks as a function of cutoff threshold. The third line shows the difference in the
number of edges between the two conditions.
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Patient 2 for whom it did not. The range of both pH
and BE values decreased for Patient 2 when pressors
were administered.
Discussion
We set out to show that giving drugs to ICU patients can
modify their physiology on a wider scale than expected
from the main effect of the drugs, and that correlation net-
works can be used to visualize these changes. We have
shown that changes in both univariate measures and cor-
relation networks describing physiological states are asso-
ciated with pressors being given to critical care patients
and demonstrated a method to visualize these differences
as three distinct cases. The “static” case includes a core
physiology that is not associated with pressor use, while
the “sign change” and “either-or” networks show two dif-
ferent types of physiological change associated with press-
ors. After narrowing our attention to only the strongest
correlations from the original correlation networks, we
examined a set of 58 edges to demonstrate the subtlety
with which these changes can manifest in individual
patients, even in a relationship that is part of the “static”
network.
Defining physiological state is a difficult yet important
endeavor that could change the way critical care patients
receive treatment. In previous studies by our group and
others [2,12,18,19] the definition of physiologic state
was based on instantaneous values or time histories of
single physiological measurements. This approach has
been successful, giving rise to scoring systems such as
APACHE-III, the Injury Severity Score, and many sys-
tems for outcome prediction [12,16,28,29]. Those stu-
dies mainly focused either on algorithm development or
outcome scores. Here, we focused more on developing a
technique for a deeper understanding of physiology,
using a novel application of building correlation net-
works from temporally dense data.
The power of network-based analysis to discover rela-
tionships and improve clinical insight is gaining promi-
nence [20]. Constructing correlation networks out of
readily measured clinical physiological variables can be
the first step towards moving these innovative research
tools to the clinic. One primary use for these networks
might be in customization of drug therapies. For exam-
ple, Adourian, et al., have used correlation networks to
identify biomarkers for hepatic drug toxicity [21], but
also make the point that empirical approaches using
easily acquired data are likely to shed more light on com-
plex physiology than normal univariate procedures.
One potential criticism of this work is that the use of a
correlation network analysis on metabolites and variables
yields results that are already known and generally well
understood. However, it has been shown that similarly
constructed correlation networks do not match up with
those expected from interaction networks and that both
approaches contribute useful information [22]. Our work
Figure 4 Correlation networks. Correlation network diagrams showing the Spearman correlation networks after applying a threshold of |r| >
0.4 as discussed in the main text. (a) The “static” network of edges with the same directionality both with and without pressors. Red edges
indicate a negative correlation while green edges indicate a positive correlation. (b) The “either-or” network with edges present either with
pressors or without, but not both. Red/green edges as in (a) indicate edges without pressors. Orange/blue edges indicate negative/positive
correlations with pressors. Wider lines indicate a stronger correlation.
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provides more evidence in favor of visualizing physiology
via correlation networks, as ours contain unexpected
associations that do not conform to standard physiologi-
cal thinking. Establishing causation is a difficulty in this
work, as in all correlation network analyses. In this case,
some of the correlations associated only with pressors are
likely to be reflective of the reasons for giving the drugs
while others are likely to be due to the drugs. It is likely,
for example, that the negative correlation that appears
between muscle oxygen tension and heart rate when
pressors are given reflects impairment in peripheral oxy-
gen transport that drives the cardiovascular system to
work harder [30], resulting in increased heart rate that is
among the diagnostic criteria for shock [31]. At the same
time, the uncoupling of BUN from creatinine during
pressor administration while associating with heart rate
and muscle glucose does not have any clear connection
to shock or pressors. Notwithstanding this inherent
ambiguity, our method is capable of suggesting putative
physiological relationships associated with the physiolo-
gic state of a patient that could shed light on poorly
understood aspects of physiology. Future work can look
at how relationships between measurements change over
time, and can provide temporal evidence for causation by
examining network changes immediately preceding and
following the start of pressors.
To draw clinically useful conclusions about this “new”
physiology, one must also improve on our main limita-
tion of having 19 patients receive five different pressors
in various combinations. Consequently, we limit our
claims and say that the application of these methods to
high frequency multivariate physiological data provides
Figure 5 Individual patient analysis. Scatter plots with regression lines for base excess vs. pH in Patient 2 (a-b) and Patient 5 (c-d). Panels a
and c show times without pressors while panel b and d show times with pressors.
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an excellent way to discover changes in physiology asso-
ciated with varying physiologic state and we recommend
further studies to delve into the specific ways in which
this information can be put to practical use. These stu-
dies could involve more patients given well-defined
doses of individual pressors and would enable the use of
these methods to deeply understand their effects. As
additional comprehensive data sets become available -
and indeed they are currently being generated - these
methods can easily be applied in a variety of ways to
provide insight into the rapidly changing physiology of
ICU patients. Ideally, future studies could also produce
concrete treatment recommendations based on indivi-
dual patients’ physiologic state. At a minimum, though,
this sort of analysis could provide an additional source
of data for physicians to incorporate into their normal
diagnostic procedure. Furthermore, because our meth-
ods are computationally simple they lend themselves
well to eventual implementation in clinical decision sup-
port systems and improved patient monitors that incor-
porate state information.
Conclusions
We have shown that correlation networks can be built
from physiological associations and that drugs modify
these networks. Using correlation network analysis we
determined that the strength and directionality of asso-
ciations between clinical physiological variables changed
when pressors were given, both in aggregate and in indi-
vidual patients. In fact, the majority of these associations
changed when pressors were given, reinforcing the
notion that complex physiology cannot easily be mod-
eled as a single set of mathematical relationships
between metabolic variables. We also presented a proof
of concept showing that patients have inherent differ-
ences in their physiology that could be exploited by a
“personalized physiology” approach to medicine. We
also demonstrated that different drugs have differential
effects on physiological networks and that applying net-
work analysis to clinical physiology provides information
that could be useful in treating patients. Further studies
in personalized physiology that open up the middle level
of personalized medicine, a level between genes and
demographics, have the potential to change the way
drugs are evaluated during clinical trials and prescribed
in the hospital or clinic.
Additional material
Additional file 1: Empirical cumulative distribution functions for
each of the 29 variables collected in our study. Red line indicates the
distribution when pressors are being administered while the blue line
indicates the time when pressors are not being administered.
Additional file 2: Correlation network diagram showing edges that
are present and retain the same sign regardless of pressor
administration. Green edges indicate a positive Spearman correlation
while red edges indicate a negative correlation.
Additional file 3: Correlation network diagram showing edges that
are present either when pressors are being administered or not,
but not in both cases. Red/green edges indicate negative/positive
correlation coefficients without pressors. Orange/blue edges indicate
negative/positive correlations when pressors are being administered.
Wider edges indicate stronger correlations.
Additional file 4: Correlation network diagram showing the edges
that undergo a direction change when pressors are administered.
Green edges indicate a positive correlation when pressors are not being
administered - and a negative correlation when pressors are
administered. Red edges indicate the opposite.
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